257 related articles for article (PubMed ID: 26498348)
1. Variability of the characteristics of a migraine attack within patients.
Viana M; Sances G; Ghiotto N; Guaschino E; Allena M; Nappi G; Goadsby PJ; Tassorelli C
Cephalalgia; 2016 Aug; 36(9):825-30. PubMed ID: 26498348
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan.
Allais G; Bussone G; Airola G; Borgogno P; Gabellari IC; De Lorenzo C; Pavia E; Benedetto C
Neurol Sci; 2008 May; 29 Suppl 1():S186-90. PubMed ID: 18545931
[TBL] [Abstract][Full Text] [Related]
3. Predicting the response to a triptan in migraine using deep attack phenotyping: A feasibility study.
Viana M; Sances G; Terrazzino S; Zecca C; Goadsby PJ; Tassorelli C
Cephalalgia; 2021 Feb; 41(2):197-202. PubMed ID: 32955929
[TBL] [Abstract][Full Text] [Related]
4. Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis.
Cady R
Headache; 2002 Jan; 42 Suppl 1():26-31. PubMed ID: 11966861
[TBL] [Abstract][Full Text] [Related]
5. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study].
Stöckli HR; Sword A
Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591
[TBL] [Abstract][Full Text] [Related]
6. Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.
Tullo V; Valguarnera F; Barbanti P; Cortelli P; Sette G; Allais G; d'Onofrio F; Curone M; Zava D; Pezzola D; Benedetto C; Frediani F; Bussone G
Cephalalgia; 2014 May; 34(6):434-45. PubMed ID: 24363238
[TBL] [Abstract][Full Text] [Related]
7. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study.
Göbel H; Heinze A
Int J Clin Pract; 2011 Aug; 65(8):879-86. PubMed ID: 21762313
[TBL] [Abstract][Full Text] [Related]
8. A case-report of migraine "sine headache".
Taga A; Russo M; Genovese A; Manzoni GC; Torelli P
Cephalalgia; 2018 Mar; 38(3):592-594. PubMed ID: 28120618
[TBL] [Abstract][Full Text] [Related]
9. The relationship between migraine pain and other associated symptoms.
Kelman L; Tanis D
Cephalalgia; 2006 May; 26(5):548-53. PubMed ID: 16674763
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
Silberstein SD; Elkind AH; Schreiber C; Keywood C
Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with frovatriptan response in patients with migraine: A prospective, observational study.
Seo JG; Park SP
Cephalalgia; 2016 Apr; 36(5):493-8. PubMed ID: 26170008
[TBL] [Abstract][Full Text] [Related]
12. Premonitory and Accompanying Symptoms in Childhood Migraine.
Sampaio Rocha-Filho PA; Gherpelli JLD
Curr Pain Headache Rep; 2022 Feb; 26(2):151-163. PubMed ID: 35064917
[TBL] [Abstract][Full Text] [Related]
13. Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study.
Newman LC; Harper S; Jones BA; Campbell J
J Womens Health (Larchmt); 2009 Aug; 18(8):1265-73. PubMed ID: 19627225
[TBL] [Abstract][Full Text] [Related]
14. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
15. Assessing migraine disability by diary-based measurement: relationship to the characteristics of individual headache attacks.
Park JW; Shin HE; Kim JS; Lee KS
Eur J Neurol; 2008 Aug; 15(8):817-21. PubMed ID: 18549394
[TBL] [Abstract][Full Text] [Related]
16. Variability of clinical features in attacks of migraine with aura.
Hansen JM; Goadsby PJ; Charles AC
Cephalalgia; 2016 Mar; 36(3):216-24. PubMed ID: 25944814
[TBL] [Abstract][Full Text] [Related]
17. Frovatriptan in the practice of office-based neurologists/pain therapists: Results of postmarketing surveillance study ALADIN.
Wallasch TM
Adv Ther; 2010 Jan; 27(1):56-62. PubMed ID: 20140543
[TBL] [Abstract][Full Text] [Related]
18. The natural course of migraine attacks. A prospective analysis of untreated attacks compared with attacks treated with a triptan.
Linde M; Mellberg A; Dahlöf C
Cephalalgia; 2006 Jun; 26(6):712-21. PubMed ID: 16686911
[TBL] [Abstract][Full Text] [Related]
19. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic features of chronic migraine.
Yalın OÖ; Uluduz D; Özge A; Sungur MA; Selekler M; Siva A
J Headache Pain; 2016; 17():26. PubMed ID: 26975363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
